GLP-1 for South Asian Patients: Diabetes Risk & Metabolic Considerations
Introduction South Asians (people with origins in India, Pakistan, Bangladesh, Sri Lanka, Nepal, and surrounding regions) have one of the highest type 2 diabetes…
GLP-1 for People with Social Anxiety Around Eating
Social anxiety affects roughly 12% of U.S. adults at some point.
GLP-1 and Smoking Cessation: Can It Help You Quit?
The same brain circuits that semaglutide quiets for food and alcohol cravings overlap with nicotine reward pathways.
Does GLP-1 Work for People with a Slow Metabolism?
Yes. GLP-1 medications work primarily by reducing appetite, not by speeding metabolism, so a slow resting metabolic rate doesn’t block the mechanism.
GLP-1 for People with Sleep Disorders
About 39 million American adults have obstructive sleep apnea, and an estimated 25 to 30 million more have insomnia disorder.
GLP-1 Shortage Explained: Why Medications Are Hard to Find
Introduction The GLP-1 supply chain story is a case study in pharmaceutical capacity, FDA shortage rules, and what happens when demand for a class…
GLP-1 for Seniors: Age 70+ Safety Guide
Adults over 70 were not the headline group in the original obesity trials, but the data we do have is reassuring. In STEP 1 (Wilding et al.
GLP-1 for Remote Workers: Combating Sedentary Lifestyle
About 35% of U.S. workers now work remotely at least part-time, according to 2024 Bureau of Labor Statistics data.
GLP-1 During Ramadan: Fasting & Medication Management
Introduction Ramadan presents a specific challenge for GLP-1 medication users: a month of daytime fasting (no food or water from dawn to sunset) overlaid…
